About This EventNewAmsterdam Pharma (Nasdaq: NAMS), a late-stage, clinical biopharmaceutical company focused on improving outcomes for patients with metabolic diseases, visits the Nasdaq MarketSite in ...

Below is Validea's guru fundamental report for BROADCOM INC (AVGO). Of the 22 guru strategies we follow, AVGO rates highest using our Twin Momentum Investor model based on the published strategy of ...